Evolin
The computed 12-month bankruptcy probability of Evolin is 0.7% (low). The 2024 annual accounts show equity of €913k and a net result of €84k. Its solvency ranks better than 77% of 238 sector peers (fiscal year 2024). The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €913k |
| Net result | €84k |
| Better than sector | 77% |
| Active | 3 yrs |
Strong profile, led by stability.
Statistical estimate based on public sources — not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit from Starter.
See plans →| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 62.9% | 34.0% | |
| Net result | €84k | €42k | |
| Equity | €913k | €325k | |
| Gross operating margin | €140k | €67k | |
| Employees (FTE) | 0.0 | 0.0 |
| Fiscal year | 2024 |
|---|---|
| Revenue | — |
| EBITDA | €138k |
| Net profit | €84k |
| Cash flow | €87k |
| Staff costs | — |
| Income taxes | €34k |
| Dividends | — |
| Total assets | €1.45M |
| Equity | €913k |
| Debt | €539k |
| of which ≤ 1y | €216k |
| of which > 1y | €322k |
| Working capital | €-52k |
| Employees (FTE) | 0.0 |
| 2024 | |
|---|---|
| Current ratio | 0.76 |
| Quick ratio | 0.76 |
| Working capital ratio | -3.6% |
| Solvency | 62.9% |
| Debt / equity | 0.59 |
| Long-term debt ratio | 0.35 |
| Interest coverage | 7.65 |
| Gross margin | — |
| Net margin | — |
| ROA | 5.8% |
| ROE | 9.2% |
| EBITDA margin | — |
| Days sales outstanding | — |
| Days payable outstanding | — |
| Inventory turnover | — |
| Days inventory (DSI) | — |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet — Assets | ||
| TOTAL ASSETS | 20/58 | €1.45M |
| Fixed assets | 21/28 | €1.29M |
| Tangible fixed assets | 22/27 | €27k |
| Financial fixed assets | 28 | €1.26M |
| Current assets | 29/58 | €165k |
| Amounts receivable within one year | 40/41 | €158k |
| Cash & bank | 54/58 | €7k |
| Balance sheet — Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €1.45M |
| Equity | 10/15 | €913k |
| Contributions / capital | 10/11 | €762k |
| Reserves | 13 | €151k |
| Amounts payable | 17/49 | €539k |
| Amounts payable after one year | 17 | €322k |
| Amounts payable within one year | 42/48 | €216k |
| Trade debts payable within one year | 44 | €4k |
| Income statement | ||
| Gross operating margin | 9900 | €140k |
| Operating result | 9901 | €135k |
| Financial income | 75 | €824 |
| Financial charges | 65 | €18k |
| Result before taxes | 9903 | €118k |
| Income taxes | 67/77 | €34k |
| Net result for the period | 9904 | €84k |
| Result to be appropriated | 9905 | €84k |
| NACE primary | Financial services(64210) |
| Legal form | Private limited company(610) |
| Incorporation | 24-01-2023 |
| Status | Active |
| Postal code | 2440 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates — not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 13008H1370/00V000 | Flanders | 1,738 m² | 1 · 269 m² | 12.5 m · 3 fl. |
A single timeline of everything that happened to this company — publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
20-06-2024 Articles of association amended — translation of the articles and coordination of the articles
Technical details
{
"notary": {
"name": "Marie-Ghislaine Brosens",
"firm_city": null,
"firm_name": null,
"office_city": "Beerse",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2024-06-20",
"filing_date": "2024-06-18",
"act_kind_objet": "STATUTEN (VERTALING, COORDINATIE, OVERIGE WIJZIGINGEN)"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2024-06-17",
"unanimous": null
},
"statute_change": {
"kinds": [
"translation",
"coordination",
"other"
],
"scope": null,
"trigger": null,
"language_after": null,
"language_before": null
},
"bedrijfsrevisor": {
"firm_kbo": null,
"firm_name": "Kadija Amklaou, Bedrijfsrevisor",
"ibr_number": null,
"individual_name": "Kadija Amkhaou"
},
"subject_company": {
"kbo": "0797.551.321",
"name_full_after": "Evolin",
"legal_form_after": "B.V.",
"name_full_before": "Evolin",
"current_zetel_raw": "Xantenstraat 30D 2440 Geel",
"legal_form_before": "B.V."
},
"special_mandates": [
{
"holder_kbo": null,
"holder_name": "I.B.A. Integraal Bedrijfsadvies",
"scope_categories": [
"kbo",
"ub",
"btw",
"estox"
],
"with_substitution": true
}
],
"articles_modified": [
{
"summary": "Ontslag van het voorlezen van het bijzonder verslag van het bestuursorgaan.",
"new_text": null,
"change_kind": "amended",
"article_title": null,
"article_number": "5:121 \u00A7 1"
},
{
"summary": "Ontslag van het voorlezen van de aangestelde bedrijfsrevisor.",
"new_text": null,
"change_kind": "amended",
"article_title": null,
"article_number": "5:133 \u00A7 1"
},
{
"summary": "Conclusie van de bedrijfsrevisor over de inbreng in natura.",
"new_text": null,
"change_kind": "amended",
"article_title": null,
"article_number": "5:133"
}
],
"governance_change": null,
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Marie-Ghislaine Brosens",
"org_rep_person_name": null
},
"co_filed_documents": [
"uitgifte van de akte",
"geco\u00F6rdineerde statuten",
"verslag bedrijfsrevisor",
"verslag bestuurder"
],
"shareholder_rights": null,
"voorwerp_change_summary": null,
"capital_structure_change": {
"operations": [
"eigen_aandelen_inkoop"
],
"split_ratio": null,
"shares_after": null,
"shares_before": null,
"capital_after_eur": 760000.0,
"capital_before_eur": null,
"share_classes_after": []
},
"coordinated_text_lineage": null
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | Evolin |